Bydureon dosing information. Usual adult dose for diabetes type 2: Bydureon extended-release:
- Dose: 2 mg subcutaneously once every seven days; administer at any time of day, with or without meals
- Patients may switch from immediate-release exenatide to extended-release exenatide, although prior treatment with immediate-release exenatide is not necessary.
- For patients who do switch, discontinue immediate-release exenatide on initiation of extended-release; transient elevations in blood glucose may occur and generally improve within the first 2 weeks of initiation.